- Previous Close
0.570 - Open
0.590 - Bid 0.560 x --
- Ask 0.570 x --
- Day's Range
0.560 - 0.590 - 52 Week Range
0.485 - 0.870 - Volume
532,000 - Avg. Volume
683,724 - Market Cap (intraday)
354.825M - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
8.14 - EPS (TTM)
0.070 - Earnings Date Mar 27, 2024
- Forward Dividend & Yield 0.03 (5.93%)
- Ex-Dividend Date Jun 3, 2024
- 1y Target Est
--
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceutical, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibition; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It serves in the People's Republic of China, Japan, the United States, Canada, Hong Kong, Taiwan, Thailand, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.
www.kingworld.com.cn1,002
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1110.HK
Performance Overview: 1110.HK
Trailing total returns as of 6/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1110.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1110.HK
Valuation Measures
Market Cap
354.82M
Enterprise Value
531.08M
Trailing P/E
8.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.28
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.45
Enterprise Value/EBITDA
3.85
Financial Highlights
Profitability and Income Statement
Profit Margin
3.53%
Return on Assets (ttm)
3.78%
Return on Equity (ttm)
8.84%
Revenue (ttm)
1.08B
Net Income Avi to Common (ttm)
38.1M
Diluted EPS (ttm)
0.070
Balance Sheet and Cash Flow
Total Cash (mrq)
194.03M
Total Debt/Equity (mrq)
50.68%
Levered Free Cash Flow (ttm)
-64.91M